Aspen concludes an exclusive Women’s Health portfolio licensing agreement with Viramal Read More December 15, 2025
Aspen announces an exclusive licensing agreement with Asamedic AS for a novel formulation targeting emergency heart attack treatment. Read More November 19, 2025
Aspen reinforces Saudi market leadership with new Middle East region HQ in Riyadh Read More May 22, 2025
Aspen announces exclusive licensing agreement with Wooshin Labottach for Lidocaine 700mg medicated plasters Read More June 26, 2024
Aspen concludes exclusive European licensing agreement with Devintec Pharma for a patented women’s health medical device Read More June 12, 2024
PharmaBoardroom interview with Daniel Vella Friggieri on the merger of Aspen Europe & MENAT regions Read More June 26, 2023
Aspen, Saudi Chemical Company Holding and its subsidiary AJA Pharma enter into a memorandum of understanding Read More March 7, 2023
Aspen donates life-saving emergency relief to patients in Turkey and Syria Read More February 17, 2023
